Relugolix and radiation therapy may be a safe, effective combination for treating prostate cancer

A high impact study led by Daniel Spratt, M.D., Vincent K. Smith Chair in Radiation Oncology at University Hospitals Seidman Cancer Center demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.

CBER’s Marks points to stockpiles of H5N1 vaccine as officials monitor reported human case

WASHINGTON — The US has some stockpiles of vaccines for avian flu, FDA’s biologics head Peter Marks said Monday as public health officials raise the

April 2, 2024

Study illuminates why obesity makes ovarian cancer more deadly

Most women with ovarian cancer are diagnosed with the most advanced form of the disease. Less than a third of those diagnosed with the disease

July 20, 2023

RSV Vaccine Tied to Fewer Hospitalizations, ED Visits in Older, High-Risk Adults

The respiratory syncytial virus (RSV) vaccine (Abrysvo) was linked with fewer hospitalizations and emergency department (ED) visits in older patients during the first season of

October 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.